Todd Boudreaux, Director of Content

FacebookTwitterEmail
 

Director of Content

Todd was diagnosed with Type 1 diabetes in 2000, and has been unofficially advocating for T1D ever since. Before joining the team at Beyond Type 1, Todd wrote and produced television shows for Discovery Channel, Travel Channel and Animal Planet. When he’s not in the office, you can usually find him at a baseball game, traveling or drawing on his Etch A Sketch. You can also follow him on instagram @toddboo.

For all editorial inquiries, please contact editor@beyondtype1.org.

 

 

 

 


Written by Todd

One Drop Announces New Overnight Hypo Predictions and Long-Term Health Forecasts at ADA 2020


One Drop unveiled new AI-powered predictions for blood glucose, A1C, blood pressure, and weight up to six months in advanceREAD MORE

How to Measure Success in Pediatric Diabetes Care


In a spirited debate, speakers made their case for whether the primary metric for pediatric diabetes success should be A1C or Time in Range (TIR).READ MORE

Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 After Starting on FreeStyle Libre


The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.READ MORE

Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020


Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.READ MORE

IndyCar Driver Charlie Kimball Talks COVID-19 + Racing with T1D


Indy racecar driver Charlie Kimball lives with Type 1 diabetes and talks about what's ahead for this season and how it's been impacted by the coronavirus pandemic.READ MORE

“Jesse Was Here (More Lasagna, Please): Feeding the Soul of a Grieving Mother” Book Review


In a new book, Michelle Bauer recounts her son Jesse’s life with T1D, interactions following his death, and practical advice for those experiencing grief.READ MORE

COVID-19 Antibody Tests, When to Seek Emergency Care, Hydroxychloroquine + More with Dr. Anne Peters


Dr. Peters spoke with BT1 about the unreliability of current COVID-19 antibody tests, when to seek emergency care, hydroxychloroquine use and more.READ MORE

New Program Offers $35 Monthly Copays for Lilly Insulins


Eli Lilly announced a new program that allows people in the US to fill their monthly prescription of Lilly insulin for $35 per month with a copay card.READ MORE

T1D + COVID-19 Positive — One Nurse’s Story


Ashlee shares her experience having now had COVID-19, and what it means as a healthcare professional and a person living with Type 1 diabetes.READ MORE

The Latest on COVID-19 From Dr. Anne Peters


Dr. Anne Peters took time to check in about COVID-19 and give us her latest updates, especially pertaining to diabetes care as this situation is unfolding.READ MORE

A Deeper Look at Beta Cell Research with Frank Martin


Frank Martin is a Director of Research at JDRF, focusing on beta cell therapy. Recently he spoke with Beyond Type 1 about JDRF’s mission to cure T1D, some of the current obstacles of beta cell transplants, exciting trials currently underway and more.READ MORE

A Deeper Look at Immunotherapy Research with Jessica Dunne


Jessica Dunne is a Senior Director of Research at JDRF, focusing on prevention of Type 1 diabetes. Recently she spoke with Beyond Type 1 about what it means to prevent T1D, the importance of population screening, exciting trials currently underway and more.READ MORE

Insulin Access in a Pandemic: An Interview with Wade Neucks of Lilly Diabetes


Beyond Type 1 chatted with Wade Neucks of Lilly Diabetes about expectations of insulin access in the midst of the COVID-19 pandemic.READ MORE

Dexcom G7 Updates with CEO Kevin Sayer


Dexcom CEO Kevin Sayer discusses Dexcom’s international strategy, the next-generation Dexcom G7, and the response to the Dexcom Follow outage last Fall.READ MORE

COVID-19 Diabetes Supply Chain Updates


Here, you'll find continuous updates on the status of the diabetes supply chain, with up to date information from all major insulin and device manufacturers as it relates to COVID-19.READ MORE

COVID-19 Q+A with Endocrinologist Dr. Anne Peters


Dr. Anne Peters, a clinical diabetologist at the USC, recently took the time to answer questions about COVID-19 sourced from the Beyond Type 1 community. READ MORE

Shoot for the Stars: John Cutter on Living His Dream as a Firefighter with T1D


John Cutter always knew he wanted to be a firefighter when he grew up. But when he was diagnosed with Type 1 Diabetes, a wrench was thrown into those plans.READ MORE

Omnipod Closed Loop Technology to be Compatible with both Abbott and Dexcom CGMs


Abbott and Dexcom announced formal partnerships with Insulet to be compatible as CGMs on the Omnipod Horizon Automated Insulin Delivery System. READ MORE

Everyone with Diabetes Should Have Access to CGM: Dr. Aaron Neinstein’s Take


Dr. Neinstein was one of four featured experts during Beyond Type 1’s #KnowledgeDrop Series, discussing the future of diabetes care, focusing specifically on technology, data, and emerging therapies.READ MORE

DKA On The Rise: Dr. Satish Garg Explains Why


"15-20% of Type 2 diabetes cases are misdiagnosed. These patients have antibody positive Type 1 diabetes. So clearly their Type 1 diabetes was totally mistreated and misdiagnosed. That's why the actual number of people who are living worldwide who are insulin requiring is more like 150 to 200 million people, out of which probably closer to 70-80 million people actually have classical Type 1 diabetes, if you define by antibody positive."READ MORE

Addressing the Emotional Side of Diabetes with Dr. Bill Polonksy


"So I started walking around the waiting room and introducing myself to people, saying, 'Hey, could you tell me what's living with diabetes like for you?' And the most remarkable thing happened — The very first person I asked this looked at me and said, 'Thank you — no one's ever asked me that question before.'"READ MORE

Este Haim On Burnout + Bolusing For Pizza


Este Haim, a member of sister pop trio Haim, talks to Beyond Type 1 about how diabetes burnout influenced her verse on the band's new track "Hallelujah" READ MORE

One on One with ADA CEO Tracey Brown


Tracey D. Brown is the CEO of the American Diabetes Association. BT1 had a candid conversation with Brown about community needs + what's ahead for the ADA.READ MORE

Steady Health: A New Type of Diabetes Care


Steady Health offers a new way to manage diabetes, by providing constant access to your care team and a deep analysis of your CGM data. READ MORE

Implanted PEC-01 Cells Capable of Producing Insulin According to New Data Presented from ViaCyte


ViaCyte presented preliminary data from their PEC-Direct trial, showing that PEC-01 cells are capable of producing insulin in patients with Type 1 diabetes.READ MORE

The Future of Diabetes Care with AADE President Karen Kemmis


Karen Kemmis, the President of AADE recently spoke with Beyond Type 1 about the exciting changes happening at AADE and the future of diabetes care. READ MORE

Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk


Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.READ MORE

Senate Bill Aims to Cut Price of Insulin by 75%


The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.READ MORE

New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care


The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.READ MORE

The Future of Dexcom with CEO Kevin Sayer


Beyond Type 1 recently caught up with Dexcom CEO Kevin Sayer to discuss expected updates to G6, the future of Dexcom G7, and continued concerns over access.  READ MORE

One on One With Insulet CEO Shacey Petrovic


Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.READ MORE

New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.


The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.READ MORE

JDRF Advocates Urge Congress to Renew Funding for T1D Research


On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.READ MORE

Dash, Tidepool Loop, Horizon: the Future of Omnipod


The Omnipod Dash is now widely available, and two hybrid closed loops, Omnipod Horizon and DASH + Tidepool are expected in the second half of 2020.READ MORE

Exciting Trial Results for Tandem’s Control-IQ Hybrid Closed Loop System


Participants using Control-IQ saw an increased time in range, lowered HbA1c, and less time in hyperglycemia and hypoglycemia.READ MORE

Tidepool and Medtronic Announce Collaboration on Interoperable Automated Insulin Pump


Tidepool announced that they have partnered with Medtronic to create an interoperable automated insulin pump system.READ MORE

Country Music Star Eric Paslay Talks Life With T1D


Beyond Type 1 recently spoke with Eric Paslay about life with diabetes, the importance of role models, and what he hopes to accomplish with his new podcast.READ MORE

Actress Jennifer Bartels on Embracing Life with T1D


Beyond Type 1 recently talked to actress Jennifer Bartels about her diagnosis, how she is bringing awareness to T1D, and her plans for the future.READ MORE

FDA Approves New Treatment for Diabetic Retinopathy


Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.READ MORE

Express Scripts Won’t Cover Lilly’s Generic Insulin


The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. READ MORE

DIY Loop Now Compatible with Omnipod


Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.READ MORE

Insulin Manufacturers and PBMs Testify Before Congress


The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.READ MORE

JDRF’s New CEO Aaron Kowalski Talks to Beyond Type 1


Beyond Type 1 spoke with newly-appointed JDRF CEO Aaron Kowalski about his priorities, the future of T1D research and treatment options, and how his diabetes has informed his work. READ MORE

First Oral Medication to Treat T1D Approved in Europe


The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2READ MORE

Pharma Execs Testify Before Senate on High Drug Prices


Executives from pharmaceutical companies were called on to testify before the Senate Finance Committee to explain the soaring cost of prescription drug prices in the U.S.READ MORE

Insulin Manufacturers Called on to Explain Skyrocketing Prices


On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.  READ MORE

The Future of Glucagon with Xeris CEO Paul Edick


Beyond Type 1 talks to Paul Edick, President and CEO of Xeris Pharmaceuticals, about their revolutionary glucagon pen.READ MORE

Government Shutdown Leads to Insulin Rationing


Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.READ MORE

1 on 1 with Soccer Star Maxim Speed


Maxim Speed is an online sensation who certainly lives up to his name. The 12-year-old from Oahu, Hawaii has been playing soccer practically from the time he could walk. Max recently spoke with Beyond Type 1 about his diagnosis, what it’s like playing soccer with T1D, and his plans for the future.READ MORE

Hiking the Appalachian Trail with T1D


When Rachel Hemond set out on her 21st birthday to hike the Appalachian Trail, it was the culmination of a life full of adventure and exploration.READ MORE

Introducing Francine Kaufman: Newest Member of Science Advisory Council


Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the global diabetes landscape, and the future of T1D.READ MORE

Caitlin Kinnunen: Type 1 on Broadway


Caitlin Kinnunen opens up about The Prom, how she manages her diabetes on stage, the importance of having a strong support system, and her aspirations for the future. READ MORE

The Deductible Problem


Over the past two decades, deductibles have been steadily rising and a greater percentage of Americans have been enrolling in high deductible health plans.READ MORE

Runner Spotlight: Gary and Katrina Pilkington


Health and fitness are a priority in Gary and Katrina's lives so that they can set an example for their daughter and inspire others to do the same!READ MORE

Diabetes Patients Are Being Denied Access to Life-Changing Technology


A recent survey conducted by Dexcom and Beyond Type 1 has revealed that many people with Type 1 diabetes are unaware of continuous glucose monitoring.READ MORE

Runner Spotlight: Patrick Votruba


Beyond Type Run Marathoner Patrick Votruba talks about his diagnosis, experience running in ultra marathons, and how he has been training for the 2018 NYC Marathon.READ MORE

Runner Spotlight: Léonor Marchand


Léonor Marchand talks with Beyond Type 1 about her running inspiration, how she's preparing for the NYC Marathon, and advice for people living with Type 1 diabetes.READ MORE

Research Shows Fridges Might Be Destroying Insulin


A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. READ MORE